Anthrax-Related MMWRs

Anthrax and Animal Products

• Inhalation Anthrax Associated with Dried Animal Hides — Pennsylvania and New York City, 2006
  • MMWR 2006 Mar 17;55(10):280-282

Bioterrorism

• Notice to Readers: Protecting Building Environments from Airborne Chemical, Biologic, or Radiologic Attacks
  • MMWR 2002 Sep 6; 51(35):789
• Update: Investigation of Bioterrorism-Related Anthrax — Connecticut, 2001
  • MMWR 2001 Dec 7; 50(48):1077-1079
• Update: Investigation of Bioterrorism-Related Inhalational Anthrax —Connecticut, 2001
  • MMWR 2001 Nov 30; 50(47):1049-1051
• Update: Investigation of Bioterrorism-Related Anthrax, 2001
  • MMWR 2001 Nov 16; 50(45):1008-1010
• Investigation of Bioterrorism-Related Anthrax & Adverse Events from Antimicrobial Prophylaxis
  • MMWR 2001 Nov 9; 50(44):973-976
• Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
  • MMWR 2001 Nov 2; 50(43)
• Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
  • MMWR 2001 Oct 26; 50(42)
• Recognition of Illness Associated with the Intentional Release of a Biologic Agent
  • MMWR 2001 Oct 19; 50(41)

 

Top of Page

Diagnosis

• Notice to Readers: Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus anthracis Contamination on Surfaces in Buildings
  • MMWR 2001 Dec 7; 50(48):1077-1079
• Notice to Readers: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax
  • MMWR 2001 Nov 9; 50(44):973-976
• Recognition of Illness Associated with the Intentional Release of a Biologic Agent
  • MMWR 2001 Oct 19; 50(41) 

 

Top of Page

Guidelines and Recommendations

• Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident: CDC Recommendations (2015)
  • MMWR 2015 Dec 4; 64 (4)
• Medical Examiners, Coroners, and Biologic Terrorism: A Guidebook for Surveillance and Case Management
  • MMWR 2004 Jun 11; 53(RR-8)
• Notice to Readers: Interim Guidelines for Investigation of and Response to Bacillus Anthracis Exposures
  • MMWR 2001 Nov 9; 50(44):973-976
• Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
  • MMWR 2001 Nov 2; 50(43)
• Notice to Readers: Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
  • MMWR 2001 Nov 2; 50(43)
• Notice to Readers: Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites in which Mail is Handled or Processed
  • MMWR 2001 Nov 2; 50(43)
• Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
  • MMWR 2001 Oct 26; 50(42)
• Use of Anthrax Vaccine in the United States, ACIP Recommendations
  • MMWR 2000 Dec 15; 49(RR-15)
• Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthrax
  • MMWR 2001 Nov 16; 50(45):1008-1010

 

Top of Page

Pregnancy

• Notice to Readers: Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
  • MMWR 2001 Nov 2; 50(43)
• Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthrax
  • MMWR 2001 Nov 16; 50(45):1008-1010

Top of Page

 

Prophylaxis

• Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
  • MMWR 2010 Jul 23; 59(RR-6)
• Notice to Readers: Status of U.S. Department of Defense Preliminary Evaluation of the Association of Anthrax Vaccination and Congenital Anomalies
  • MMWR 2002 Feb 15; 51(6)
• Use of Anthrax Vaccine in the United States, ACIP Recommendations
  • MMWR 2000 Dec 15; 49(RR-15) 
• Surveillance for Adverse Events Associated with Anthrax Vaccination – U.S. Department of Defense, 1998-2000
  • MMWR 2000 Apr 28; 49(16)
• Notice to Readers: Evaluation of Postexposure Antibiotic Prophylaxis to Prevent Anthrax
  • MMWR 2002 Jan 25; 51(3)

Top of Page

 

Worker Safety

• Follow-Up of Deaths Among U.S. Postal Service Workers Potentially Exposed to Bacillus anthracis—District of Columbia, 2001–2002
  • MMWR 2003 Oct 3; 52(39)
• Adverse Events Associated with Anthrax Prophylaxis Among Postal Employees — New Jersey, New York City, & the District of Columbia Metropolitan Area, 2001
  • MMWR 2001 Nov 30; 50(47):1049-1051
• Notice to Readers: Occupational Health Guidelines for Remediation Workers at Bacillus anthracis-Contaminated Sites—United States, 2001–2002
  • MMWR 2002 Sep 6; 51(35):789
• Notice to Readers: Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites in which Mail is Handled or Processed
  • MMWR 2001 Nov 2; 50(43)